H. VanBrocklin

University of California San Francisco

Poster Author Of 5 e-Posters

Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Neuroimaging 261

261 - 18F-YJH08, a novel radioligand targeting the glucocorticoid receptor to understand the pathobiology of cancer and major depressive disease. (ID 1106)

Session Name
Preclinical Probes for Neuroimaging II
Speakers
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Preclinical Probes for Neuroimaging
Presentation Number
261
General Clinical Specialties -> Outcomes/Infections Disease/Pulmonary 540

540 - Imaging viral load and T cell activation in HIV: Tools for cure development (ID 360)

Session Name
Infection/Pulmonary/Outcomes
Speakers
Presentation Topic
General Clinical Specialties -> Outcomes/Infections Disease/Pulmonary
Presentation Number
540
General Clinical Specialties -> Outcomes/Infections Disease/Pulmonary 545

545 - First-in-human total-body PET imaging of HIV with 89Zr-VRC01 on the EXPLORER (ID 357)

Session Name
Infection/Pulmonary/Outcomes
Speakers
Presentation Topic
General Clinical Specialties -> Outcomes/Infections Disease/Pulmonary
Presentation Number
545
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Prostate/GU 590

590 - Interim Assessment of Kidney Dosimetry and Pharmacokinetics in a Phase I Study of CTT1403, a novel 177Lu-labeled Small Molecule Inhibitor of Prostate Specific Membrane Antigen (ID 773)

Session Name
Prostate: PSMA radioligand therapy
Speakers
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Prostate/GU
Presentation Number
590
Molecular Targeting Probes - Radioactive & Nonradioactive -> Automation & Technology Development 1003

1003 - Doxorubicin-[18F]Fluorobenzamide: Automated synthesis for Chemofilter Development (ID 1168)

Session Name
Automation & Process Development (Poster Session)
Speakers
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Automation & Technology Development
Presentation Number
1003